CALCIMAR Drug Patent Profile
✉ Email this page to a colleague
When do Calcimar patents expire, and what generic alternatives are available?
Calcimar is a drug marketed by Sanofi Aventis Us and is included in two NDAs.
The generic ingredient in CALCIMAR is calcitonin salmon. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CALCIMAR?
- What are the global sales for CALCIMAR?
- What is Average Wholesale Price for CALCIMAR?
Summary for CALCIMAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 30 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CALCIMAR at DailyMed |
![CALCIMAR drug patent expirations Drug patent expirations by year for CALCIMAR](/p/graph/s/t/CALCIMAR-patent-expirations.png)
US Patents and Regulatory Information for CALCIMAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | CALCIMAR | calcitonin salmon | INJECTABLE;INJECTION | 017769-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | CALCIMAR | calcitonin salmon | INJECTABLE;INJECTION | 017497-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |